Leiber Company   Report issue

For profit
Founded: Damme Germany (1954)
Status: Left NME R&D (2016)

Organization Overview

First Clinical Trial
2006
NCT00403689
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

beta-glucans (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1